Filing Flows

Filing Flows › Accendra Health (ACH) › Next earnings date

Accendra Health (ACH) earnings: missed the estimate

Accendra Health (ACH) reported on Nov 5, 2026 and missed the EPS estimate: −$0.23 against −$0.09 (-151.6%). Revenue was $602M for Q3 2026, -14% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−151.6% vs estimate
Beat rate40%

The last report

Accendra Health reported revenue of $602M for the third quarter 2026 (-14% Y/Y), net loss $19.7M: Diabetes $196M, Sleep therapy $144M, Home respiratory therapy $88.9M, Ostomy $55.2M. How it makes money → · Every quarter →

Accendra Health: EPS against the estimate, last 5 reportsAccendra Health: EPS against the estimate, last 5 reportsEstimateReported$0.23$0.25Oct 25$0.22$0.21Feb 26−$0.10−$0.04May 26−$0.09−$0.19Aug 26−$0.09−$0.23Nov 26
Latest (Nov 26): Estimate −$0.09, Reported −$0.23.

Accendra Health's latest quarter

Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%, net loss $19.7M, operating cash flow −$17.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Accendra Health beat earnings?

Accendra Health (ACH) reported on Nov 5, 2026 and missed the EPS estimate: −$0.23 against −$0.09 (-151.6%).

When does ACH report earnings?

The next date is not set yet.

Does Accendra Health usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.